Insmed Incorporated
INSM
$133.11
$0.940.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.37% | -8.93% | -6.81% | 26.64% | -91.36% |
| Total Depreciation and Amortization | 22.97% | 18.35% | 0.91% | 1.06% | -6.60% |
| Total Amortization of Deferred Charges | -4.78% | 2.50% | 9.71% | -10.45% | -1.63% |
| Total Other Non-Cash Items | 82.89% | 774.82% | -87.55% | -62.04% | 482.85% |
| Change in Net Operating Assets | 114.43% | -335.01% | 278.77% | -139.76% | 171.76% |
| Cash from Operations | 21.56% | -33.73% | -8.33% | -47.14% | 33.19% |
| Capital Expenditure | 65.40% | -48.70% | -83.57% | 45.61% | -44.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 155.65% | -34.68% | 113.86% | -- | -100.00% |
| Cash from Investing | 183.33% | -38.97% | 113.13% | -14,693.91% | -102.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -282.01% | -2.92% | -4.26% | -2.02% | -3.86% |
| Issuance of Common Stock | 2,796.93% | 116.38% | -96.55% | -49.11% | 19,192.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 200.00% |
| Cash from Financing | 2,858.16% | -81.80% | -59.89% | -49.17% | 25,760.13% |
| Foreign Exchange rate Adjustments | 12.29% | 159.47% | -181.84% | 367.30% | 27.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 680.48% | -262.20% | 111.92% | -220.62% | 474.36% |